Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2016

14.03.2016 | Original Article – Clinical Oncology

Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998–2013): a population-based analysis

verfasst von: M. Rottmann, T. Beck, A. Burges, C. Dannecker, M. Kiechle, D. Mayr, A. Schlesinger-Raab, G. Schubert-Fritschle, J. Engel

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective was to identify trends in surgery and the outcomes of squamous cell vulvar cancer in a population-based setting.

Methods

A total of 1113 patients with squamous cell vulvar cancer diagnosed between 1998 and 2013 in the catchment area of the Munich Cancer Registry (population approximately 4.6 million) were analysed. Trends in prognostic factors and treatment were examined by comparing patients diagnosed between 1998 and 2008 with those diagnosed between 2009 and 2013. Cumulative incidence was used to calculate time to local (LR) and lymph node recurrence (LNR). Survival was analysed by the Kaplan–Meier method, calculation of relative survival (RS), and a Cox model.

Results

The high median age at diagnosis of 75 years did not change significantly over time. In addition, no changes in the subsite of tumour or grading were noted. A decrease in patients undergoing complete vulvectomy from 27.7 to 17.8 % (p < 0.001) as well as an increase in the use of sentinel lymph node biopsy from 11.4 to 39.1 % (p < 0.001) was observed. However, time to LR (from 19 to 19 %) and time to LNR (from 9 to 9 %) as well as 5-year overall survival (from 55 to 55 %) and RS (from 66 to 63 %) were not significantly altered. After adjustment for prognostic factors, less radical locoregional surgery had no influence on survival.

Conclusion

Less radical locoregional surgery in vulvar cancer is increasingly implemented. Locoregional recurrence and survival have not been affected by these changes and are likely accompanied by an improvement in quality of life.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Akhtar-Danesh N, Elit L, Lytwyn A (2014) Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study. Gynecol Oncol 134(2):314–318CrossRefPubMed Akhtar-Danesh N, Elit L, Lytwyn A (2014) Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study. Gynecol Oncol 134(2):314–318CrossRefPubMed
Zurück zum Zitat Alberta Health Services (2013) Clinical practice guideline. Squamous cell carcinoma of the vulva Alberta Health Services (2013) Clinical practice guideline. Squamous cell carcinoma of the vulva
Zurück zum Zitat Baandrup L, Varbo A, Munk C, Johansen C, Frisch M, Kjaer SK (2011) In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978–2007—a nationwide population-based study. Gynecol Oncol 122(1):45–49CrossRefPubMed Baandrup L, Varbo A, Munk C, Johansen C, Frisch M, Kjaer SK (2011) In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978–2007—a nationwide population-based study. Gynecol Oncol 122(1):45–49CrossRefPubMed
Zurück zum Zitat British Gynaecological Cancer Society (2014) Guidelines for the diagnosis and management of vulval cancer. Royal College of Obstetricians & Gynaecologists British Gynaecological Cancer Society (2014) Guidelines for the diagnosis and management of vulval cancer. Royal College of Obstetricians & Gynaecologists
Zurück zum Zitat Buttmann-Schweiger N, Klug SJ, Luyten A, Holleczek B, Heitz F, du Bois A et al (2015) Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999–2011. A population-based cancer registry analysis. PLoS ONE 10(5):e0128073CrossRefPubMedPubMedCentral Buttmann-Schweiger N, Klug SJ, Luyten A, Holleczek B, Heitz F, du Bois A et al (2015) Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999–2011. A population-based cancer registry analysis. PLoS ONE 10(5):e0128073CrossRefPubMedPubMedCentral
Zurück zum Zitat Covens A, Vella ET, Kennedy EB, Reade CJ, Jimenez W, Le T (2015) Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis and guideline recommendations. Gynecol Oncol 137(2):351–361CrossRefPubMed Covens A, Vella ET, Kennedy EB, Reade CJ, Jimenez W, Le T (2015) Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis and guideline recommendations. Gynecol Oncol 137(2):351–361CrossRefPubMed
Zurück zum Zitat Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG)/Deutsche Krebsgesellschaft (DKG) (2008) Arbeitsgemeinschaft Gynäkologische Onkologie. Interdisziplinäre S2 k-Leitlinie für die Diagnostik und Therapie des Vulvakarzinoms und seiner Vorstufen. Zuckschwerdt, München Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG)/Deutsche Krebsgesellschaft (DKG) (2008) Arbeitsgemeinschaft Gynäkologische Onkologie. Interdisziplinäre S2 k-Leitlinie für die Diagnostik und Therapie des Vulvakarzinoms und seiner Vorstufen. Zuckschwerdt, München
Zurück zum Zitat Ederer F, Heise H (1959) Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10. End results evaluation section. National Cancer Institute Ederer F, Heise H (1959) Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10. End results evaluation section. National Cancer Institute
Zurück zum Zitat Gunther V, Malchow B, Schubert M, Andresen L, Jochens A, Jonat W et al (2014) Impact of radical operative treatment on the quality of life in women with vulvar cancer—a retrospective study. Eur J Surg Oncol 40(7):875–882CrossRefPubMed Gunther V, Malchow B, Schubert M, Andresen L, Jochens A, Jonat W et al (2014) Impact of radical operative treatment on the quality of life in women with vulvar cancer—a retrospective study. Eur J Surg Oncol 40(7):875–882CrossRefPubMed
Zurück zum Zitat Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG (2008) New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol 109(3):340–345CrossRefPubMed Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG (2008) New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol 109(3):340–345CrossRefPubMed
Zurück zum Zitat Ignatov T, Eggemann H, Burger E, Costa SD, Ignatov A (2015) Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 142(2):489–495CrossRef Ignatov T, Eggemann H, Burger E, Costa SD, Ignatov A (2015) Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 142(2):489–495CrossRef
Zurück zum Zitat Kalbfleisch J, Prentice R (1980) The statistical analysis of failure time data. Wiley, New York Kalbfleisch J, Prentice R (1980) The statistical analysis of failure time data. Wiley, New York
Zurück zum Zitat Lai J, Elleray R, Nordin A, Hirschowitz L, Rous B, Gildea C et al (2014) Vulval cancer incidence, mortality and survival in England: age-related trends. BJOG 121(6):728–738 (discussion 739) CrossRefPubMed Lai J, Elleray R, Nordin A, Hirschowitz L, Rous B, Gildea C et al (2014) Vulval cancer incidence, mortality and survival in England: age-related trends. BJOG 121(6):728–738 (discussion 739) CrossRefPubMed
Zurück zum Zitat Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N et al (2015) Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 107(3):dju426CrossRefPubMedPubMedCentral Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N et al (2015) Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 107(3):dju426CrossRefPubMedPubMedCentral
Zurück zum Zitat McCann GA, Cohn DE, Jewell EL, Havrilesky LJ (2015) Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: a cost-utility analysis. Gynecol Oncol 136(2):300–304CrossRefPubMed McCann GA, Cohn DE, Jewell EL, Havrilesky LJ (2015) Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: a cost-utility analysis. Gynecol Oncol 136(2):300–304CrossRefPubMed
Zurück zum Zitat Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I et al (2010) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11(7):646–652CrossRefPubMed Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I et al (2010) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11(7):646–652CrossRefPubMed
Zurück zum Zitat Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A et al (2014) Management and outcomes for elderly women with vulvar cancer over time. BJOG 121(6):719–727 (discussion 727) CrossRefPubMed Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A et al (2014) Management and outcomes for elderly women with vulvar cancer over time. BJOG 121(6):719–727 (discussion 727) CrossRefPubMed
Zurück zum Zitat Reade CJ, Eiriksson LR, Mackay H (2014) Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecol Oncol 132(3):780–789CrossRefPubMed Reade CJ, Eiriksson LR, Mackay H (2014) Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecol Oncol 132(3):780–789CrossRefPubMed
Zurück zum Zitat Robison K, Roque D, McCourt C, Stuckey A, DiSilvestro PA, Sung CJ et al (2014) Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone. Gynecol Oncol 133(3):416–420CrossRefPubMed Robison K, Roque D, McCourt C, Stuckey A, DiSilvestro PA, Sung CJ et al (2014) Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone. Gynecol Oncol 133(3):416–420CrossRefPubMed
Zurück zum Zitat Schuurman MS, van den Einden LC, Massuger LF, Kiemeney LA, van der Aa MA, de Hullu JA (2013) Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer 49(18):3872–3880CrossRefPubMed Schuurman MS, van den Einden LC, Massuger LF, Kiemeney LA, van der Aa MA, de Hullu JA (2013) Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer 49(18):3872–3880CrossRefPubMed
Zurück zum Zitat Slomovitz BM, Coleman RL, Oonk MH, van der Zee A, Levenback C (2015) Update on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol 138(2):472–477CrossRefPubMed Slomovitz BM, Coleman RL, Oonk MH, van der Zee A, Levenback C (2015) Update on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol 138(2):472–477CrossRefPubMed
Zurück zum Zitat Sobin L, Wittekind C (2002) TNM classification of malignant tumours. International Union Against Cancer (UICC), 6th edn. Wiley-Liss, New York Sobin L, Wittekind C (2002) TNM classification of malignant tumours. International Union Against Cancer (UICC), 6th edn. Wiley-Liss, New York
Zurück zum Zitat Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours. International union against cancer (UICC), 7th edn. Wiley-Liss, New York Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours. International union against cancer (UICC), 7th edn. Wiley-Liss, New York
Zurück zum Zitat Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH et al (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26(6):884–889CrossRefPubMed Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH et al (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26(6):884–889CrossRefPubMed
Zurück zum Zitat Wills A, Obermair A (2013) A review of complications associated with the surgical treatment of vulvar cancer. Gynecol Oncol 131(2):467–479CrossRefPubMed Wills A, Obermair A (2013) A review of complications associated with the surgical treatment of vulvar cancer. Gynecol Oncol 131(2):467–479CrossRefPubMed
Metadaten
Titel
Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998–2013): a population-based analysis
verfasst von
M. Rottmann
T. Beck
A. Burges
C. Dannecker
M. Kiechle
D. Mayr
A. Schlesinger-Raab
G. Schubert-Fritschle
J. Engel
Publikationsdatum
14.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2135-2

Weitere Artikel der Ausgabe 6/2016

Journal of Cancer Research and Clinical Oncology 6/2016 Zur Ausgabe

Original Article – Cancer Research

SOX2 inhibits metastasis in gastric cancer

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.